Portal de investigação
Comparação de escala de qualidade de vida na insuficiência cardíaca com fração de ejeção reduzida quando realizada no domicílio ou na consulta hospitalar.
Dados básicos
- Código:
- Estudo Observacional Académico (QualidadeIC)
- Protocolo:
- Estudo Observacional Académico (QualidadeIC)
- EUDRACT:
- NCT:
- Centro:
- Dotação:
- Ano de início:
- 2021
- Ano de conclusão:
Objectivos do projeto
Tipo de Estudo: Estudo Observacional – Iniciativa do Investigador; Subtipo: Outro; Fase: Cross-sectional; Natureza do Promotor: Academia – Tipo não comercial; Tipo de Centro: Unicêntrico - Cuidados Secundários - Centro de Ensaio: CHUSJ - Doença investigada: Insuficiência Cardíaca – Participantes recrutados: 30
Documentos
- Não há documentos
Participantes
Unidades de investigação
Stakeholders - Promotores
Outputs do ensaio clínico
Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
Moreira-Costa, L; (...); Lourenço, AP
Article. 2024
Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes
Ferreira, J.; (...); Neves, J.
Article. 10.1002/ejhf.2660. 2022
Albiglutide in patients with type 2 diabetes and heart failure: a post-hoc analysis from Harmony Outcomes.
Ferreira, JP; (...); Neves, JS
Article. 2022
Assessing the influence of perfusion on cardiac microtissue maturation: A heart-on-chip platform embedding peristaltic pump capabilities
Cruz Moreira, D; (...); Rasponi, M
Article. 10.1002/bit.27836. 2021
Authors reply in response to a letter on "Standardized approach for extubation during extracorporeal membrane oxygenation in severe acute respiratory distress syndrome: a prospective observational study"
Roncon Albuquerque, R.; (...); Paiva, JA
Letter. 10.1186/s13613-023-01215-9. 2023
Clinical and Pathophysiologic Insights of Free triiodothyronine/Free thyroxine Ratio in Patients with Heart Failure with Preserved Ejection Fraction: Data from the NETDiamond Cohort
Leite, AR; (...); Leite-Moreira, A
Article. 10.1159/000530136. 2023
Changes in health-related quality of life and treatment effects in chronic heart failure: a meta-analysis.
Angelico Goncalves, A; (...); Ferreira, JP
Article. 2023
Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction
Leite, S; (...); Louren?o, A.
Article. 10.1177/10742484211034253. 2021
Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials
Leite, AR; (...); Ferreira, J.
Article. 10.1111/dom.14707. 2022
Effect of glucagon-like peptide-1 receptor agonists on cardiovascular events in overweight or obese adults without diabetes: A meta-analysis of placebo-controlled randomized trials.
Leite, AR; (...); Ferreira, JP
Article. 2022
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR-Preserved analysis
Ferreira, JP; (...); Anker, S
Article. 10.1002/ejhf.3180. 2024
Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes
Ribeiro, Eduarda; (...); Vale, Nuno
Article. 10.3390/jcm13144113. 2024
Enhancing Urological Cancer Treatment: Leveraging Vasodilator Synergistic Potential with 5-FU for Improved Therapeutic Outcomes.
Ribeiro, E; (...); Vale, N
Article. 2024
Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors
Marques, P; (...); Ferreira, JP
Article. 10.1002/ejhf.2992. 2023
Fenofibrate and Heart Failure Outcomes in Patients With Type 2 Diabetes: Analysis From ACCORD
Ferreira, J.; (...); Leite Moreira, A.
Article. 10.2337/dc21-1977. 2022
FLEXIBLE PIEZOELECTRIC PATCHES FOR IMPROVEMENT OF HEART TISSUE ACTIVITY
Monteiro, LM; (...); Nascimento, DS
Meeting Abstract. 2022
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes
Neves, J.; (...); Md, JPF
Article. 10.1016/j.jacc.2023.05.048. 2023
GLP-1 Receptor Agonist Therapy With and Without SGLT2 Inhibitors in Patients With Type 2 Diabetes.
Neves, JS; (...); Md, JPF
Article. 2023
Glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes with and without chronic heart failure: A meta-analysis of randomized placebo-controlled outcome trials.
Ferreira, JP; (...); Neves, JS
Article. 2023
Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure
Ferreira, J.; (...); Neves, J.
Review. 10.1210/clinem/dgad398. 2023
Impact of prediabetes in heart failure with preserved ejection fraction: the NetDiamond cohort
Borges-Canha, M; (...); Leite-Moreira, A
Meeting Abstract. 2021
In Vitro Drug Repurposing: Focus on Vasodilators
Ribeiro, Eduarda; (...); Vale, Nuno
Review. 10.3390/cells12040671. 2023
Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury
Garcia, Bruno; (...); Herpain, Antoine
Article. 10.1186/s40635-024-00638-3. 2024
Interleukin-6, infection and cardiovascular outcomes in acute heart failure: Findings from the EDIFICA registry
Vasques-Nóvoa, F; (...); Frioes, F
Article. 10.1016/j.cyto.2022.156053. 2022
Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock
Garcia, B; (...); Herpain, A
Article. 10.1186/s13054-022-04161-3. 2022
Myocardial oedema: pathophysiological basis and implications for the failing heart
Vasques?N?voa, F; (...); Roncon Albuquerque, R.
Review. 10.1002/ehf2.13775. 2022
Myocardial RNA Sequencing Reveals New Potential Therapeutic Targets in Heart Failure with Preserved Ejection Fraction
Inacio, JM; (...); Belo, JA
Article. 10.3390/biomedicines11082131. 2023
New Peptide Functionalized Nanostructured Lipid Carriers with CNS Drugs and Evaluation Anti-proliferative Activity
Silva, S; (...); Vale, N.
Article. 10.3390/ijms23137109. 2022
New Peptide Functionalized Nanostructured Lipid Carriers with CNS Drugs and Evaluation Anti-proliferative Activity.
Silva, S; (...); Vale, N
Article. 2022
Pharmacological Targeting of Senescence with ABT-263 in Experimental Heart Failure with Preserved Ejection Fraction
Silva, E; (...); Nascimento, D.
Meeting Abstract. 10.1093/cvr/cvac066.107. 2022
Relaxin-2, pathophysiological insights and outcomes in heart failure with preserved ejection fraction: Findings from the NETDiamond cohort
Pintalhao, M; (...); Leite Moreira, A.
Article. 10.1016/j.ijcard.2022.07.037. 2022
Risk of adverse events with liraglutide in heart failure with reduced ejection fraction: A post hoc analysis of the FIGHT trial
Neves, J.; (...); Ferreira, J.
Article. 10.1111/dom.14862. 2023
Sodium-glucose co-transporter inhibitors in insulin-treated diabetes: a meta-analysis
Ferreira, JP; (...); Leite-Moreira, A
Article. 10.1530/EJE-20-1484. 2021
Standardized approach for extubation during extracorporeal membrane oxygenation in severe acute respiratory distress syndrome: a prospective observational study
Roncon Albuquerque, R.; (...); Paiva, J.
Article. 10.1186/s13613-023-01185-y. 2023
TARGETING PREMATURE AGING TO IMPROVE HFPEF
Silva, E. D.; (...); Nascimento, D. S.
Meeting Abstract. 2023
The Effect of the Stress Induced by Hydrogen Peroxide and Corticosterone on Tryptophan Metabolism, Using Human Neuroblastoma Cell Line (SH-SY5Y).
Correia, AS; (...); Vale, N
Article. 2023
The senolyitc drug ABT-263 reverses HFpEF-associated inflammation, endothelial inflammation and fibrosis
Silva, EDS; (...); Nascimento, DSN
Meeting Abstract. 2021
Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction
Sebastiao, MJ; (...); Gomes-Alves, P
Article. 10.3390/biomedicines10112943. 2022
